Skip to main content
Premium Trial:

Request an Annual Quote

Enzymatics Gets ISO Certifications

NEW YORK (GenomeWeb News) – Molecular biology enzymes manufacturer Enzymatics today said that it has received ISO 13485:2003 and 9001:2000 standards certification from TÜV SÜD America.

The Beverly, Mass.-based firm makes proteins that are used for research and diagnostics purposes with a focus on nucleic acid detection technologies. It provides enzymes and buffer solutions for the Polonator, a low-cost sequencing system developed by George Church's group at Harvard Medical School and sold by the Dover unit of Danaher-Motion.

ISO 13485:2003 is a globally recognized standard that specifies requirements for a quality management system and is intended to facilitate harmonized medical device regulatory requirements for quality management systems. ISO 9001:2000 shares significant overlap with 13485:2003, while including a focus on continuous improvement and customer satisfaction, said Enzymatics.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.